Navigation Links
Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
Date:3/26/2008

NEW YORK, March 26 /PRNewswire/ -- Golub Capital today announced that it has provided a $29.5 million one-loan debt financing (through Golub Capital's proprietary GOLD facility) in support of the recapitalization of ExtruMed, a market leader providing precision tubing solutions to the medical industry. Founded in 1990, and based in Placentia, Calif., ExtruMed's products are used in medical devices and technology serving various therapy areas including cardiology, vascular therapies, endosurgery, neurology, Ob/Gyn and urology. GOLD financings are proprietary Golub Capital One-Loan Debt facilities.

ExtruMed has been owned by Inverness Graham Investments and Wedbush Capital Partners since September 2005. The debt provided by Golub Capital will be used to refinance the company's existing debt and provide a cash dividend to the sponsors.

"We are very excited to have closed our first transaction with two private equity sponsors of the caliber of Inverness Graham and Wedbush Capital. We are pleased that we were able to provide them with the appropriate solution for their financing needs," said Golub Capital Managing Director Charlie Riceman. "ExtruMed is a true leader in its field. We have been extremely impressed with the deep knowledge and experience of the ExtruMed management team and are excited to watch ExtruMed continue to build out its capabilities and grow."

"We are pleased to close our first transaction with Golub Capital. The flexibility in structure and spirit of partnership demonstrated by Golub has contributed to a very efficient process. We are pleased to have them as partners in ExtruMed and look forward to future transactions together." says Scott Kehoe, a Managing Principal at Inverness Graham Investments.

Golub Capital lends to broad range of U.S.-based mid-market companies and initially invests between $5 million and $75 million with additional capital available for growth.

About Golub Capital

Golub Capital is an active provider of GOLD (Golub Capital's One-Loan Debt Facility), senior and subordinated debt, second lien debt, preferred stock, and co-investment equity to middle market companies. The firm is committed to being a value-added and user-friendly partner to owners, senior management and transaction sponsors. With a broad investment mandate and long-term time horizon, Golub Capital has a high level of flexibility in structuring investments. For more information, please visit http://www.golubcapital.com.


'/>"/>
SOURCE Golub Capital
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross & Blue Shield Association
2. Super Model Cindy Crawford will be Honored at DKMS Linked Against Leukemia Gala on May 7th at Capitale
3. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
4. InforMedix Retains Murdock Capital Partners
5. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
6. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
7. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
8. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
9. Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference
10. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
11. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: